Couch RB. Advances in influenza virus vaccine research. Ann N Y Acad Sci.1993;685:803-812.
Riddiough MA, Sisk JE, Bell JC. Influenza vaccination: cost-effectiveness and public policy. JAMA.1983;249:3189-3195.
Sullivan KM, Monto AS, Longini Jr IM. Estimates of the US health impact of influenza. Am J Public Health.1993;83:1712-1716.
Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory
Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep.1999;48(RR-4):1-29.
Nichol KL, Lind A, Margolis KL.
et al. The effectiveness of vaccination against influenza in healthy, working
adults. N Engl J Med.1995;333:889-893.
Clements ML, Betts RF, Murphy BR. Advantage of live attenuated cold-adapted influenza A virus over inactivated
vaccine for A/Washington/80 (H3N2) wild-type virus infection. Lancet.1984;1:705-708.
Gorse GJ, Belshe RB, Munn NJ. Superiority of live attenuated compared with inactivated influenza
A virus vaccines in older, chronically ill adults. Chest.1991;100:977-984.
Gorse GJ, Campbell MJ, Otto EE.
et al. Increased anti-influenza A virus cytotoxic T-cell activity following
vaccination of the chronically ill elderly with live attenuated or inactivated
influenza virus vaccine. J Infect Dis.1995;172:1-10.
Gorse GJ, Otto EE, Powers DC.
et al. Induction of mucosal antibodies by live attenuated and inactivated
influenza virus vaccines in the chronically ill elderly. J Infect Dis.1996;173:285-290.
Clover RB, Crawford S, Glezen WP.
et al. Comparison of heterotypic protection against influenza A/Taiwan/86
(H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses.
J Infect Dis.1991;163:300-304.
Piedra PA, Glezen WP. Influenza in children: epidemiology, immunity, and vaccines. Semin Pediatr Infect Dis.1991;2:140-146.
Belshe RB, Mendelman PM, Treanor J.
et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal
influenzavirus vaccine in children. N Engl J Med.1998;338:1405-1412.
Clements ML, O'Donnell S, Levine MM.
et al. Dose response of A/Alaska/6/77 cold-adapted reassortant vaccine virus
in adult volunteers: role of local antibody in resistance to infection with
vaccine. Infect Immun.1983;40:1044-1051.
Murphy BR, Clements ML, Madore HP.
et al. Dose response of cold-adapted, reassortant influenza A/California/10/78
virus (H1N1) in adult volunteers. J Infect Dis.1984;149:814-816.
Clements ML, Snyder MH, Sears SD.
et al. Evaluation of the infectivity, immunogenicity, and efficacy of cold-adapted
influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers.
J Infect Dis.1990;161:869-877.
Treanor JJ, Betts RF. Evaluation of live attenuated cold-adapted influenza B/Yamagata/16/88
reassortant virus vaccine in healthy adults. J Infect Dis.1993;168:455-459.
Treanor JJ, Betts RF, Kotloff K.
et al. Efficacy of trivalent, live, cold-adapted (CAIV-T) and inactivated
(TIV) vaccines in prevention of virus infection and illness following challenge
of adults with wild-type influenza A(H1N1), A(H3N2), and B viruses. Vaccine.In press.
Edwards KM, Dupont WD, Westrich MK.
et al. A randomized controlled trial of cold-adapted and inactivated vaccine
for the prevention of influenza A disease. J Infect Dis.1994;169:68-79.
Centers for Disease Control and Prevention. Update: influenza activity—United States and worldwide, 1996-97
season, and composition of the 1997-98 influenza vaccine. MMWR Morb Mortal Wkly Rep.1997;46:325-330.
Zeigler BL, Bulley N. A voice information system supporting compliance in the Aviron FluMist
vaccine trial. In: Proceedings of the 4th Workshop on Interactive Voice Technology
for Telecommunications Applications (IVTTA); September 29-30, 1998; Torino,
Centers for Disease Control and Prevention. Update: influenza activity—United States, 1997-98 season. MMWR Morb Mortal Wkly Rep.1998;47:196-200.
Centers for Disease Control and Prevention. Update: influenza activity—United States and worldwide, 1997-98
season, and composition of the 1998-99 influenza vaccine. MMWR Morb Mortal Wkly Rep.1998;47:280-284.
Gruber W, Belshe R, Mendelman P.
et al. Immunologic response to heterotypic H3N2 strains after live intranasal
or inactivated intramuscular influenza vaccine in children: abstracts of the
IDSA 36th Annual Meeting. Clin Infect Dis.1998;27:933.
Belshe R, Iacuzio D, Mendelman P, Wolff M. Efficacy of a trivalent live attenuated intranasal influenza vaccine
in children. In: Abstracts of the 38th Interscience Conference on Antimicrobial
Agents and Chemotherapy; September 24-27, 1998; San Diego, Calif.
Bridges CB, Fukuda K, Thompson W.
et al. Cost effectiveness of influenza vaccine against a drifted influenza
A(H3N2) strain among healthy adults, 1997-98. In: Program and abstracts of the Infectious Diseases Society of America
36th Annual Meeting; November 12-15, 1998; Denver, Colo.
Edmondson Jr WP, Rothenberg R, White PW, Gwaltney Jr JM. A comparison of subcutaneous, nasal, and combined influenza vaccination,
II: protection against natural challenge. Am J Epidemiol.1971;93:480-486.
Edmondson KW, Graham DSM, Warburton MF. A clinical trial of influenza vaccine in Canberra. Med J Aust.1970;2:6-13.
Batey D. A case study of influenza vaccine and its impact on absenteeism in
the work place: a randomized clinical trial at Exxon Company, USA. Presented at: Work Group Meeting on Improving the Performance of
Influenza and Pneumococcal Vaccines in Older Adults; November 14-15, 1995;
Smith JWG, Pollard R. Vaccination against influenza: five-year study in the Post Office.
Leighton L, Williams M, Aubery D, Parker SH. Sickness absence following a campaign of vaccination against influenza
in the workplace. Occup Med.1996;46:146-150.
Wilde MA, McMillan JA, Serwint J.
et al. Effectiveness of influenza vaccine in health care professionals: a
randomized trial. JAMA.1999;281:908-913.
Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract
infections, and bronchitis by ambulatory care physicians. JAMA.1997;278:901-904.
Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance: a call for action
by clinicians, public health officials, and patients. JAMA.1997;278:944-945.
Orts K, Sheridan JF, Robinson-Whelen S.
et al. The reliability and validity of a structured interview for the assessment
of infectious illness symptoms. J Behav Med.1995;18:517-529.